Vertex Pharmaceuticals Incorporated (VRTX) SEC filings
VRTX SEC filings moved a median of -0.42% by the close. VRTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VRTX overview →
53 measured VRTX SEC filing events.
Where these VRTX SEC filings landedvs 53 measured VRTX SEC filing reactions
| Middle 50% of VRTX SEC filing reactions | -1.00% to +0.83% |
|---|---|
| Median reaction (to close) | -0.42% |
| Measured reactions | 53 |
Point-in-time · zero look-ahead
Half of the 53 VRTX SEC filing events with a measured close landed between -1.00% and +0.83%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K VERTEX PHARMACEUTICALS For: Aug 27 | SEC filing · Form 8-K | +0.48% | +0.78% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.19% | -0.55% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Aug 03 | SEC filing · Form 8-K | +2.12% | +1.57% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Jul 06 | SEC filing · Form 8-K | -2.31% | -1.46% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 13 | SEC filing · Form 8-K | -0.50% | -0.71% | |
| Form S-8 VERTEX PHARMACEUTICALS | SEC filing · Form S-8 | -0.50% | -0.71% | |
| Form S-8 POS VERTEX PHARMACEUTICALS | SEC filing · Form S-8 | -0.50% | -0.71% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.41% | +1.08% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 04 | SEC filing · Form 8-K | -2.12% | -2.20% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Apr 28 | SEC filing · Form 8-K | +0.50% | +0.83% | |
| Form DEFA14A VERTEX PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.50% | +0.83% | |
| Form ARS VERTEX PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -0.07% | -0.80% | |
| Form DEF 14A VERTEX PHARMACEUTICALS For: May 13 | SEC filing · Form DEF | -0.07% | -0.80% | |
| Form DEFA14A VERTEX PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.07% | -0.80% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Mar 31 | SEC filing · Form 8-K | +0.58% | -0.42% | |
| Form 10-K VERTEX PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -0.98% | -2.48% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Feb 12 | SEC filing · Form 8-K | +3.08% | +3.89% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -0.36% | -0.17% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Nov 03 | SEC filing · Form 8-K | -1.28% | +1.59% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.17% | +2.63% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Aug 04 | SEC filing · Form 8-K | -2.30% | -8.40% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 19 | SEC filing · Form 8-K | +0.03% | +1.17% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 14 | SEC filing · Form 8-K | -0.02% | +2.28% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -1.44% | -2.84% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 05 | SEC filing · Form 8-K | -2.96% | -2.95% | |
| Form ARS VERTEX PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +1.89% | -2.01% | |
| Form DEF 14A VERTEX PHARMACEUTICALS For: May 14 | SEC filing · Form DEF | +1.89% | -2.01% | |
| Form DEFA14A VERTEX PHARMACEUTICALS | SEC filing · Form DEFA14A | +1.89% | -2.01% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Mar 28 | SEC filing · Form 8-K | -0.81% | -0.20% | |
| Form 10-K VERTEX PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.72% | -0.76% | |
| Form S-3ASR VERTEX PHARMACEUTICALS | SEC filing · Form S-3ASR | +0.72% | -0.76% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Feb 04 | SEC filing · Form 8-K | +0.76% | -1.00% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Dec 20 | SEC filing · Form 8-K | -0.42% | -0.04% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -2.61% | -2.32% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Nov 04 | SEC filing · Form 8-K | -1.21% | +3.50% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Aug 15 | SEC filing · Form 8-K | +0.40% | +2.31% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.61% | +1.36% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Aug 01 | SEC filing · Form 8-K | +2.19% | +0.60% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Jun 27 | SEC filing · Form 8-K | +0.50% | -0.95% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 20 | SEC filing · Form 8-K | -0.39% | +0.26% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 15 | SEC filing · Form 8-K | -0.12% | +1.39% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.40% | +1.33% | |
| Form 8-K VERTEX PHARMACEUTICALS For: May 06 | SEC filing · Form 8-K | -1.33% | +0.94% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Apr 10 | SEC filing · Form 8-K | -0.65% | -1.01% | |
| Form ARS VERTEX PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -0.67% | +0.59% | |
| Form DEF 14A VERTEX PHARMACEUTICALS For: May 15 | SEC filing · Form DEF | -0.67% | +0.59% | |
| Form DEFA14A VERTEX PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.67% | +0.59% | |
| Form 10-K VERTEX PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -0.63% | -1.13% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Feb 05 | SEC filing · Form 8-K | -1.19% | -2.95% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Dec 08 | SEC filing · Form 8-K | +0.06% | +0.03% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Dec 05 | SEC filing · Form 8-K | -0.69% | -0.51% | |
| Form 10-Q VERTEX PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -0.95% | -1.00% | |
| Form 8-K VERTEX PHARMACEUTICALS For: Nov 06 | SEC filing · Form 8-K | -1.31% | +0.23% |
Keep exploring
More VRTX: earnings → · analyst actions → · VRTX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CESCA THERAPEUTICS INC COMMON (KOOL) | 736 | -0.01% | 37% |
| AIMMUNE THERAPEUTICS (AIMT) | 734 | -0.29% | 40% |
| AbbVie Inc. (ABBV) | 731 | 0.00% | 50% |
| INSYS THERAPEUTICS (INSY) | 731 | +0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.